The Gastric Service at Memorial Center, in collaboration with the Departments of Pathology and Hematology and the Physiology Section of the Division of Experimental Surgery, The Sloan Kettering Institute, has completed a scientific exhibit on the Treatment of Cancer of the Stomach.
The exhibit first deals with an attempt to find the causes of failure after definitive resections have been performed for the treatment of cancer of the stomach. This study involves postmortem examination of resection survivors carried out in the hospitals of the metropolitan area of New York. The patients survived operation and subsequently died months or years later, and eventually came to postmortem examination. A recurrence rate of 50% was observed in the gastric remnant, as well as a high incidence of metastasis in the perigastric tissues. It was then determined to give the patient what might be considered the maximum surgical effort. This operative specimen included the
PACK GT, McNEER GP, BRASFIELD RD, et al. Treatment of Gastric Cancer. AMA Arch Surg. 1957;75(5):863–870. doi:10.1001/archsurg.1957.01280170173055
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: